These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 34867702)
1. Association Between Myasthenia Gravis and Memory: A Systematic Review and Meta-Analysis. Zhou X; Zhou Y; Hua J; Xue Q Front Neurol; 2021; 12():680141. PubMed ID: 34867702 [No Abstract] [Full Text] [Related]
2. Association between myasthenia gravis and cognitive disorders: a PRISMA-compliant meta-analysis. Zhou X; Cao S; Hou J; Gui T; Zhu F; Xue Q Int J Neurosci; 2023 Dec; 133(9):987-998. PubMed ID: 35285401 [TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis. Isshiki Y; Mimura O; Gomi F Jpn J Ophthalmol; 2020 Nov; 64(6):628-634. PubMed ID: 32936398 [TBL] [Abstract][Full Text] [Related]
4. Reduced quality of life in myasthenia gravis patients: A study on 185 patients from China. Wu X; Li RY; Ye XB; Wang N Front Neurol; 2022; 13():1072861. PubMed ID: 36712441 [TBL] [Abstract][Full Text] [Related]
5. The use of eculizumab in ventilator-dependent myasthenia gravis patients. Usman U; Chrisman C; Houston D; Haws CC; Wang A; Muley S Muscle Nerve; 2021 Aug; 64(2):212-215. PubMed ID: 34008175 [TBL] [Abstract][Full Text] [Related]
6. Different characteristics of nonthymomatous generalized myasthenia gravis with and without oropharyngeal involvement. Yu L; Li J; Ma S; Jiang J; Wang T; Gamliel Z; Jing Y; Zhang X; Krasna MJ Ann Thorac Surg; 2007 Nov; 84(5):1694-8. PubMed ID: 17954087 [TBL] [Abstract][Full Text] [Related]
7. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate. Li F; Li Z; Chen Y; Bauer G; Uluk D; Elsner A; Swierzy M; Ismail M; Meisel A; Rückert JC Eur J Cardiothorac Surg; 2020 Mar; 57(3):478-487. PubMed ID: 31628812 [TBL] [Abstract][Full Text] [Related]
8. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis. Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800 [TBL] [Abstract][Full Text] [Related]
9. Response to treatment in pediatric ocular myasthenia gravis. Xu L; Castro D; Reisch JS; Iannaccone ST Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555 [TBL] [Abstract][Full Text] [Related]
10. Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis. Li M; Ge F; Guo R; Ruan Z; Gao Y; Niu C; Lin H; Zhao Z; Zhou Y; Li Z; Chang T Ther Adv Neurol Disord; 2019; 12():1756286419876521. PubMed ID: 35173803 [TBL] [Abstract][Full Text] [Related]
11. Association between myasthenia gravis and cognitive function: A systematic review and meta-analysis. Mao Z; Yin J; Lu Z; Hu X Ann Indian Acad Neurol; 2015; 18(2):131-7. PubMed ID: 26019407 [TBL] [Abstract][Full Text] [Related]
12. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients. Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837 [TBL] [Abstract][Full Text] [Related]
13. Correlation between neutrophil-to-lymphocyte ratio and severity of myasthenia gravis in adults: A retrospective study. Duan Z; Jia A; Cui W; Feng J J Clin Neurosci; 2022 Dec; 106():117-121. PubMed ID: 36279714 [TBL] [Abstract][Full Text] [Related]
14. Assessment of oropharyngeal swallowing dysfunction in myasthenia gravis patients presenting with difficulty in swallowing. Kumai Y; Miyamoto T; Matsubara K; Samejima Y; Yamashita S; Ando Y; Orita Y Auris Nasus Larynx; 2019 Jun; 46(3):390-396. PubMed ID: 30392978 [TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor: A noval biomarker upregulates in myasthenia gravis and correlates with disease severity and relapse. Huang X; Li H; Zhang Z; Wang Z; Du X; Zhang Y Cytokine; 2024 Mar; 175():156485. PubMed ID: 38159470 [TBL] [Abstract][Full Text] [Related]
16. Factors affecting outcome in ocular myasthenia gravis. Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R; Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163 [TBL] [Abstract][Full Text] [Related]
18. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response. Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625 [TBL] [Abstract][Full Text] [Related]
19. [Neuropsychological performance in patients with myasthenia gravis]. Eizaguirre MB; Aguirre F; Yastremiz C; Vanotti S; Villa A Medicina (B Aires); 2017; 77(2):117-120. PubMed ID: 28463217 [TBL] [Abstract][Full Text] [Related]